| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 12 | 2016 | 169 | 1.480 |
Why?
|
| Low Back Pain | 9 | 2022 | 54 | 1.340 |
Why?
|
| Chronic Pain | 9 | 2023 | 127 | 1.280 |
Why?
|
| Massage | 6 | 2015 | 18 | 1.250 |
Why?
|
| Cluster Analysis | 5 | 2022 | 89 | 1.040 |
Why?
|
| Internet | 9 | 2014 | 231 | 1.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 6 | 2014 | 51 | 0.990 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2023 | 322 | 0.960 |
Why?
|
| Humans | 71 | 2023 | 17611 | 0.920 |
Why?
|
| Hypertension | 7 | 2014 | 500 | 0.870 |
Why?
|
| Outcome Assessment (Health Care) | 6 | 2017 | 228 | 0.850 |
Why?
|
| Clinical Competence | 3 | 2016 | 99 | 0.850 |
Why?
|
| Breast Neoplasms | 10 | 2016 | 949 | 0.850 |
Why?
|
| Electronic Health Records | 8 | 2023 | 681 | 0.760 |
Why?
|
| Neck Pain | 3 | 2015 | 12 | 0.730 |
Why?
|
| Mindfulness | 5 | 2022 | 27 | 0.720 |
Why?
|
| Research Design | 7 | 2020 | 374 | 0.710 |
Why?
|
| Models, Statistical | 5 | 2022 | 177 | 0.710 |
Why?
|
| Product Surveillance, Postmarketing | 5 | 2014 | 95 | 0.690 |
Why?
|
| Propensity Score | 2 | 2019 | 85 | 0.690 |
Why?
|
| Rubella | 1 | 2019 | 6 | 0.660 |
Why?
|
| Mumps | 1 | 2019 | 12 | 0.650 |
Why?
|
| Chickenpox | 1 | 2019 | 35 | 0.640 |
Why?
|
| Vaccines, Combined | 1 | 2019 | 80 | 0.640 |
Why?
|
| Seizures, Febrile | 1 | 2019 | 42 | 0.640 |
Why?
|
| Measles | 1 | 2019 | 24 | 0.640 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 62 | 0.630 |
Why?
|
| Biometry | 2 | 2009 | 13 | 0.630 |
Why?
|
| Chickenpox Vaccine | 1 | 2019 | 91 | 0.620 |
Why?
|
| Antihypertensive Agents | 4 | 2014 | 161 | 0.610 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 501 | 0.580 |
Why?
|
| Female | 44 | 2022 | 12608 | 0.570 |
Why?
|
| Middle Aged | 34 | 2022 | 7911 | 0.540 |
Why?
|
| Adult | 33 | 2022 | 7598 | 0.540 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 40 | 0.530 |
Why?
|
| Gastric Bypass | 3 | 2022 | 71 | 0.520 |
Why?
|
| Pharmaceutical Services | 2 | 2013 | 34 | 0.500 |
Why?
|
| Geography | 2 | 2015 | 39 | 0.490 |
Why?
|
| Male | 35 | 2020 | 10008 | 0.490 |
Why?
|
| Treatment Outcome | 14 | 2022 | 1259 | 0.460 |
Why?
|
| Bariatric Surgery | 3 | 2022 | 128 | 0.460 |
Why?
|
| Aged | 27 | 2023 | 6095 | 0.450 |
Why?
|
| Stress, Psychological | 5 | 2022 | 141 | 0.440 |
Why?
|
| Clinical Protocols | 4 | 2016 | 43 | 0.430 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 598 | 0.420 |
Why?
|
| Self-Assessment | 1 | 2012 | 14 | 0.420 |
Why?
|
| Gastrectomy | 3 | 2022 | 46 | 0.400 |
Why?
|
| Washington | 12 | 2019 | 374 | 0.390 |
Why?
|
| Diet | 4 | 2020 | 365 | 0.380 |
Why?
|
| Computer Simulation | 4 | 2022 | 81 | 0.380 |
Why?
|
| Cohort Studies | 8 | 2022 | 2570 | 0.370 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 107 | 0.370 |
Why?
|
| Mass Screening | 5 | 2017 | 661 | 0.370 |
Why?
|
| Residence Characteristics | 4 | 2014 | 248 | 0.350 |
Why?
|
| Primary Health Care | 4 | 2019 | 766 | 0.350 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 7 | 0.340 |
Why?
|
| Prospective Studies | 8 | 2023 | 1267 | 0.320 |
Why?
|
| Yoga | 3 | 2016 | 26 | 0.320 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 120 | 0.320 |
Why?
|
| Telemedicine | 3 | 2023 | 182 | 0.310 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2016 | 382 | 0.310 |
Why?
|
| Radiology | 4 | 2012 | 8 | 0.300 |
Why?
|
| United States | 13 | 2020 | 3956 | 0.290 |
Why?
|
| Biostatistics | 3 | 2016 | 10 | 0.280 |
Why?
|
| Diagnostic Errors | 3 | 2012 | 28 | 0.280 |
Why?
|
| Quality Improvement | 3 | 2016 | 189 | 0.260 |
Why?
|
| Health Promotion | 3 | 2017 | 280 | 0.250 |
Why?
|
| Obesity | 6 | 2020 | 837 | 0.250 |
Why?
|
| False Positive Reactions | 4 | 2012 | 26 | 0.240 |
Why?
|
| Population Surveillance | 2 | 2019 | 263 | 0.240 |
Why?
|
| Socioeconomic Factors | 7 | 2019 | 630 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 748 | 0.230 |
Why?
|
| Young Adult | 13 | 2017 | 2427 | 0.220 |
Why?
|
| Data Collection | 4 | 2012 | 256 | 0.220 |
Why?
|
| Nutrition Policy | 2 | 2020 | 18 | 0.210 |
Why?
|
| Infant | 3 | 2019 | 1171 | 0.210 |
Why?
|
| Housing | 2 | 2015 | 39 | 0.210 |
Why?
|
| Regression Analysis | 5 | 2017 | 297 | 0.210 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 613 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2020 | 102 | 0.200 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2023 | 59 | 0.200 |
Why?
|
| Computer-Assisted Instruction | 2 | 2012 | 10 | 0.200 |
Why?
|
| Bias | 2 | 2019 | 102 | 0.200 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1309 | 0.200 |
Why?
|
| Education, Medical, Continuing | 2 | 2012 | 30 | 0.190 |
Why?
|
| Health Status Disparities | 2 | 2015 | 146 | 0.190 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 211 | 0.190 |
Why?
|
| Herpes Zoster | 1 | 2023 | 82 | 0.190 |
Why?
|
| Muscle Stretching Exercises | 2 | 2011 | 2 | 0.190 |
Why?
|
| Occult Blood | 2 | 2019 | 153 | 0.180 |
Why?
|
| Body Mass Index | 4 | 2015 | 958 | 0.180 |
Why?
|
| Postal Service | 2 | 2019 | 72 | 0.180 |
Why?
|
| Patient Safety | 1 | 2020 | 39 | 0.170 |
Why?
|
| Colonoscopy | 2 | 2019 | 251 | 0.170 |
Why?
|
| Reference Standards | 1 | 2019 | 15 | 0.170 |
Why?
|
| Causality | 1 | 2019 | 40 | 0.170 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 1210 | 0.170 |
Why?
|
| Self Care | 2 | 2011 | 163 | 0.170 |
Why?
|
| Professional Competence | 4 | 2012 | 10 | 0.170 |
Why?
|
| Disability Evaluation | 6 | 2017 | 46 | 0.170 |
Why?
|
| Physicians | 2 | 2011 | 137 | 0.160 |
Why?
|
| Time Factors | 6 | 2020 | 1086 | 0.160 |
Why?
|
| Adolescent | 10 | 2022 | 3651 | 0.160 |
Why?
|
| Heart Arrest | 2 | 2009 | 34 | 0.160 |
Why?
|
| Emergency Medical Services | 2 | 2009 | 46 | 0.160 |
Why?
|
| Allergens | 2 | 2009 | 6 | 0.160 |
Why?
|
| Age Factors | 5 | 2012 | 917 | 0.160 |
Why?
|
| Risk Factors | 7 | 2019 | 3325 | 0.160 |
Why?
|
| Food | 2 | 2020 | 30 | 0.160 |
Why?
|
| Motivation | 1 | 2019 | 130 | 0.160 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2016 | 86 | 0.150 |
Why?
|
| Environmental Exposure | 2 | 2009 | 116 | 0.150 |
Why?
|
| Observational Studies as Topic | 2 | 2014 | 47 | 0.140 |
Why?
|
| Hotlines | 1 | 2017 | 14 | 0.140 |
Why?
|
| Fruit | 2 | 2014 | 79 | 0.140 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 415 | 0.140 |
Why?
|
| Vegetables | 2 | 2014 | 87 | 0.140 |
Why?
|
| Oral Health | 1 | 2017 | 21 | 0.140 |
Why?
|
| Catastrophization | 1 | 2016 | 4 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2017 | 298 | 0.140 |
Why?
|
| Smoking Prevention | 1 | 2017 | 54 | 0.140 |
Why?
|
| Capacity Building | 1 | 2016 | 11 | 0.140 |
Why?
|
| Physical Therapists | 1 | 2016 | 2 | 0.140 |
Why?
|
| Attitude to Health | 2 | 2019 | 164 | 0.140 |
Why?
|
| Reminder Systems | 1 | 2017 | 80 | 0.140 |
Why?
|
| Education, Medical | 1 | 2016 | 13 | 0.140 |
Why?
|
| Radiologists | 1 | 2016 | 4 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2016 | 68 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 26 | 0.130 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 91 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2016 | 62 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 65 | 0.130 |
Why?
|
| Epidemiologic Research Design | 2 | 2013 | 18 | 0.130 |
Why?
|
| Chronic Disease | 4 | 2011 | 428 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 318 | 0.120 |
Why?
|
| Asthma | 2 | 2009 | 385 | 0.120 |
Why?
|
| Registries | 3 | 2012 | 471 | 0.120 |
Why?
|
| Spatial Analysis | 1 | 2014 | 11 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 4 | 2023 | 250 | 0.120 |
Why?
|
| Poisson Distribution | 2 | 2013 | 88 | 0.120 |
Why?
|
| Sex Factors | 3 | 2012 | 643 | 0.120 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 9 | 0.120 |
Why?
|
| Back Pain | 1 | 2014 | 33 | 0.120 |
Why?
|
| Educational Status | 2 | 2013 | 200 | 0.110 |
Why?
|
| Social Class | 2 | 2013 | 120 | 0.110 |
Why?
|
| Relaxation Therapy | 2 | 2011 | 5 | 0.110 |
Why?
|
| Environment Design | 1 | 2014 | 64 | 0.110 |
Why?
|
| Food Supply | 1 | 2014 | 34 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2014 | 298 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 32 | 0.110 |
Why?
|
| Logistic Models | 3 | 2012 | 926 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2014 | 113 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 80 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2011 | 212 | 0.110 |
Why?
|
| Electronic Mail | 2 | 2011 | 51 | 0.110 |
Why?
|
| Risk | 2 | 2013 | 516 | 0.110 |
Why?
|
| Haemophilus Vaccines | 1 | 2013 | 17 | 0.110 |
Why?
|
| Health Personnel | 1 | 2014 | 124 | 0.110 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2013 | 21 | 0.110 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2013 | 23 | 0.110 |
Why?
|
| Poverty | 1 | 2014 | 166 | 0.110 |
Why?
|
| Health Status | 2 | 2011 | 298 | 0.100 |
Why?
|
| Informed Consent | 2 | 2009 | 19 | 0.100 |
Why?
|
| Equipment Safety | 1 | 2011 | 2 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 34 | 0.100 |
Why?
|
| Books | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cholesterol | 1 | 2012 | 106 | 0.100 |
Why?
|
| Quality of Life | 2 | 2023 | 507 | 0.100 |
Why?
|
| Medical History Taking | 1 | 2011 | 35 | 0.100 |
Why?
|
| Goals | 1 | 2011 | 30 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2009 | 15 | 0.100 |
Why?
|
| Travel | 1 | 2011 | 10 | 0.100 |
Why?
|
| Commission on Professional and Hospital Activities | 1 | 2010 | 1 | 0.090 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 211 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 218 | 0.090 |
Why?
|
| Office Visits | 1 | 2011 | 80 | 0.090 |
Why?
|
| Physician-Patient Relations | 2 | 2009 | 187 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2010 | 330 | 0.090 |
Why?
|
| Methods | 1 | 2010 | 6 | 0.090 |
Why?
|
| Consumer Behavior | 1 | 2010 | 29 | 0.090 |
Why?
|
| Risk Assessment | 4 | 2020 | 1097 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 2010 | 2 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 231 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 1900 | 0.090 |
Why?
|
| Urban Health | 1 | 2010 | 38 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 99 | 0.090 |
Why?
|
| Respiratory Sounds | 1 | 2009 | 12 | 0.090 |
Why?
|
| Breast | 1 | 2010 | 84 | 0.090 |
Why?
|
| Boston | 1 | 2009 | 35 | 0.090 |
Why?
|
| Truth Disclosure | 1 | 2009 | 15 | 0.080 |
Why?
|
| Health Resources | 1 | 2009 | 37 | 0.080 |
Why?
|
| Family Health | 1 | 2009 | 44 | 0.080 |
Why?
|
| Verbal Behavior | 1 | 2009 | 2 | 0.080 |
Why?
|
| Sample Size | 2 | 2022 | 29 | 0.080 |
Why?
|
| Postmenopause | 1 | 2010 | 241 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2013 | 1409 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 237 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2008 | 5 | 0.080 |
Why?
|
| Remote Consultation | 1 | 2008 | 9 | 0.080 |
Why?
|
| Community Participation | 1 | 2008 | 30 | 0.080 |
Why?
|
| Telephone | 3 | 2017 | 161 | 0.080 |
Why?
|
| Idaho | 2 | 2019 | 24 | 0.080 |
Why?
|
| Patient Care | 1 | 2008 | 35 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 2 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 24 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 130 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2007 | 1 | 0.080 |
Why?
|
| Shock, Traumatic | 1 | 2007 | 1 | 0.080 |
Why?
|
| Dextrans | 1 | 2007 | 2 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2007 | 3 | 0.070 |
Why?
|
| Oregon | 2 | 2019 | 171 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2007 | 14 | 0.070 |
Why?
|
| African Americans | 1 | 2011 | 472 | 0.070 |
Why?
|
| Observer Variation | 3 | 2011 | 37 | 0.070 |
Why?
|
| Massachusetts | 1 | 2007 | 93 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2008 | 167 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 85 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 77 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2009 | 844 | 0.070 |
Why?
|
| Weight Loss | 2 | 2022 | 303 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 709 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 1322 | 0.060 |
Why?
|
| Child | 2 | 2010 | 2474 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 304 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2022 | 2447 | 0.050 |
Why?
|
| Censuses | 2 | 2015 | 31 | 0.050 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2014 | 93 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2023 | 45 | 0.050 |
Why?
|
| Herpesvirus 3, Human | 1 | 2023 | 44 | 0.050 |
Why?
|
| Pain Management | 1 | 2022 | 58 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 186 | 0.050 |
Why?
|
| Complementary Therapies | 2 | 2014 | 46 | 0.050 |
Why?
|
| Glycated Hemoglobin A | 1 | 2022 | 216 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 145 | 0.040 |
Why?
|
| Vaccines | 2 | 2014 | 212 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2012 | 309 | 0.040 |
Why?
|
| Financial Support | 1 | 2019 | 5 | 0.040 |
Why?
|
| Quality Control | 1 | 2019 | 45 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2013 | 671 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2019 | 55 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 101 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 287 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 46 | 0.040 |
Why?
|
| Prevalence | 2 | 2011 | 884 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 454 | 0.040 |
Why?
|
| Pharmacists | 2 | 2008 | 48 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 197 | 0.040 |
Why?
|
| Dental Care | 1 | 2017 | 19 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2017 | 16 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 201 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2019 | 326 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 30 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 3 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 20 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2016 | 86 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 42 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2017 | 193 | 0.030 |
Why?
|
| Safety | 1 | 2014 | 41 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 606 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2014 | 12 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 16 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 40 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 46 | 0.030 |
Why?
|
| Food Quality | 1 | 2013 | 3 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2013 | 57 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 219 | 0.030 |
Why?
|
| Energy Intake | 1 | 2013 | 101 | 0.030 |
Why?
|
| Commerce | 1 | 2013 | 48 | 0.030 |
Why?
|
| Health Education | 1 | 2013 | 111 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2013 | 59 | 0.030 |
Why?
|
| Models, Educational | 1 | 2012 | 6 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2012 | 18 | 0.030 |
Why?
|
| Benchmarking | 1 | 2012 | 46 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2012 | 24 | 0.030 |
Why?
|
| Device Approval | 1 | 2011 | 2 | 0.020 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2011 | 3 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 17 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 54 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2013 | 325 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 351 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 114 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 381 | 0.020 |
Why?
|
| Progestins | 1 | 2010 | 25 | 0.020 |
Why?
|
| Ownership | 1 | 2010 | 15 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 27 | 0.020 |
Why?
|
| Estrogens | 1 | 2010 | 61 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 325 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2009 | 4 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 6 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 77 | 0.020 |
Why?
|
| Malpractice | 1 | 2009 | 11 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2010 | 106 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 215 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2011 | 228 | 0.020 |
Why?
|
| Resuscitation | 1 | 2008 | 3 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2010 | 181 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2008 | 44 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2008 | 43 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 7 | 0.020 |
Why?
|
| Communication | 1 | 2009 | 194 | 0.020 |
Why?
|
| Process Assessment (Health Care) | 1 | 2007 | 24 | 0.020 |
Why?
|
| Disease Management | 1 | 2008 | 135 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2008 | 254 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 108 | 0.020 |
Why?
|
| Ethnic Groups | 1 | 2010 | 485 | 0.020 |
Why?
|